Drug intelligence / Profile preview

adenosine 5'-triphosphate

Development stage
Phase 4
Lead developer
Cordex Pharma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Intravenous, Sublingual, Inhalation
01

Overview

Adenosine 5'-triphosphate (ATP) is a purine nucleotide found in every cell of the human body and serves as the primary energy carrier in cellular metabolism. It consists of an adenine base, ribose sugar, and three phosphate groups. Intracellularly, ATP provides energy for numerous biochemical processes by releasing a phosphate group through hydrolysis. Extracellularly, ATP acts as a signaling molecule via purinergic receptors (P1 and P2), influencing neurotransmission, muscle contraction, cardiac function (notably negative chronotropic and dromotropic effects), platelet aggregation, vasodilation, and other physiological processes[1][4][5]. Clinically, intravenous or sublingual ATP has been used for acute therapy of paroxysmal supraventricular tachycardia (PSVT), pulmonary hypertension, pain management during anesthesia or surgery, improving mucociliary clearance in cystic fibrosis patients when combined with sodium channel blockers[4][8], and as supportive care in advanced cancer to prevent weight loss[8]. The injectable formulation "ATPace" was developed for rapid conversion of PSVT to normal sinus rhythm[5].

Brand names
ATPace
Other names
adenosine triphosphate disodiumphosphate d'adénosineacide 5'-adénylique
02

Targets

P2RX1 (Purinergic receptor P2X 1)P2Y (P2Y receptors)

Beyond the preview

Go deeper on adenosine 5'-triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine 5'-triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call